Inventor

SUTO MARK J

US59 patents

⚠️ This page may combine multiple inventors who share the name “SUTO MARK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SUTO MARK J

WARNER LAMBERT CO

Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process

Aziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivatives

Haloalkylaminomethyl-2-nitro-1H-imidazoles

Purine derivatives

Purine derivatives

2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells

Purine derivatives

Process for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agents

2-oxazolidinone derivatives of nitroimidazoles and pharmaceutical compositions useful as sensitizing agents

Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents

Certain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediates

Quinolinecarboxylic acid antibacterial agents

Certain optically active substituted 3-pyrraidine acetic acid derivatives useful as intermediates

Substituted benzonitriles

Optically pure R-enantiomer of alpha,alpha-dilower alkyl-pyrrolidine-3-methane amines

Quinolinecarboxylic acid antibacterial agents

Quinolinecarboxylic acid antibacterial agents

Process for chiral 3-(1-amino-1,1-bisalkylmethyl)-1-substituted-pyrrolidines

Glycerine derivatives

Chiral 3-cyano-1-substituted-pyrrolidines

Quinolinecarboxylic acid antibacterial agents

SOUTHERN RES INST

Compounds for the treatment of acute and chronic kidney disease

Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors

Oxadiazoles and thiadiazoles as TGF-β inhibitors

Polymorophs of 5-aza-4′-thio-2′-deoxycytidine

Dipeptide analogs as TGF-beta inhibitors

2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases

2,5-aryl-thiazole analogs for the treatment of neurodegenerative diseases

2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases

Compounds for the treatment of acute and chronic kidney disease

Compounds for the treatment of acute and chronic kidney disease

Oxadiazoles and thiadiazoles as TGF-β inhibitors

Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors

Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors

Antiviral agents

SIGNAL PHARM INC

Quinazoline analogs and related compounds and methods for treating inflammatory conditions

Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions

Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions

Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions

Pyridopyrimidine analogs and related compounds and methods for treating inflammatory conditions

TREGA BIOSCIENCES INC

Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels

Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels

Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels

Cytokine restraining agents

ICAGEN INC

Inhibitors of ion channels

Calcium channel antagonists

CHRISTOS THOMAS EUGENE

Heterocycles as potassium channel modulators

Heterocycles as potassium channel modulators

HOUGHTEN PHARM INC

Cytokine restraining agents

FULP ALAN

Inhibitors of ion channels